Literature DB >> 23924600

Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Lilach Toker1, Yuly Bersudsky2, Inbar Plaschkes3, Vered Chalifa-Caspi3, Gerard T Berry4, Roberto Buccafusca4, Dieder Moechars5, R H Belmaker2, Galila Agam1.   

Abstract

The inositol-depletion hypothesis proposes that lithium attenuates phosphatidylinositol signaling. Knockout (KO) mice of two genes (IMPA1 or Slc5a3), each encoding for a protein related to inositol metabolism, were studied in comparison with lithium-treated mice. Since we previously demonstrated that these KO mice exhibit a lithium-like neurochemical and behavioral phenotype, here we searched for pathways that may mediate lithium's/the KO effects. We performed a DNA-microarray study searching for pathways affected both by chronic lithium treatment and by the KO of each of the genes. The data were analyzed using three different bioinformatics approaches. We found upregulation of mitochondria-related genes in frontal cortex of lithium-treated, IMPA1 and Slc5a3 KO mice. Three out of seven genes differentially expressed in all three models, Cox5a, Ndufs7, and Ndufab, all members of the mitochondrial electron transfer chain, have previously been associated with bipolar disorder and/or lithium treatment. Upregulation of the expression of these genes was verified by real-time PCR. To further support the link between mitochondrial function and lithium's effect on behavior, we determined the capacity of chronic low-dose rotenone, a mitochondrial respiratory chain complex I inhibitor, to alter lithium-induced behavior as measured by the forced-swim and the amphetamine-induced hyperlocomotion paradigms. Rontenone treatment counteracted lithium's effect on behavior, supporting the proposition suggested by the bioinformatics analysis for a mitochondrial function involvement in behavioral effects of lithium mediated by inositol metabolism alterations.The results provide support for the notion that mitochondrial dysfunction is linked to bipolar disorder and can be ameliorated by lithium. The phenotypic similarities between lithium-treated wild-type mice and the two KO models suggest that lithium may affect behavior by altering inositol metabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23924600      PMCID: PMC3870788          DOI: 10.1038/npp.2013.194

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

Review 3.  Neural and developmental actions of lithium: a unifying hypothesis.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

4.  Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea.

Authors:  Gerard T Berry; Shuang Wu; Roberto Buccafusca; Jun Ren; Linda W Gonzales; Philip L Ballard; Jeffrey A Golden; Martin J Stevens; John J Greer
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

5.  Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.

Authors:  T O'Donnell; S Rotzinger; T T Nakashima; C C Hanstock; M Ulrich; P H Silverstone
Journal:  Brain Res       Date:  2000-10-13       Impact factor: 3.252

6.  Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP.

Authors:  Chihiro Kawaguchi; Kazuhiro Tanaka; Yasushi Isojima; Norihito Shintani; Hitoshi Hashimoto; Akemichi Baba; Katsuya Nagai
Journal:  Biochem Biophys Res Commun       Date:  2003-10-10       Impact factor: 3.575

7.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Authors:  L M Hallcher; W R Sherman
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

8.  Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.

Authors:  W Timothy O'Brien; Amber DeAra Harper; Fernando Jové; James R Woodgett; Silvia Maretto; Stefano Piccolo; Peter S Klein
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

9.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

10.  Anti-anhedonic activity of long-term lithium treatment in rats exposed to repeated unavoidable stress.

Authors:  Giovanna Marchese; Simona Scheggi; Maria Elena Secci; Maria Graziella De Montis; Carla Gambarana
Journal:  Int J Neuropsychopharmacol       Date:  2013-08       Impact factor: 5.176

View more
  18 in total

Review 1.  Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.

Authors:  Gin S Malhi; Tim Outhred
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

2.  Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Authors:  Steffen Durinck; Eric W Stawiski; Andrea Pavía-Jiménez; Zora Modrusan; Payal Kapur; Bijay S Jaiswal; Na Zhang; Vanina Toffessi-Tcheuyap; Thong T Nguyen; Kanika Bajaj Pahuja; Ying-Jiun Chen; Sadia Saleem; Subhra Chaudhuri; Sherry Heldens; Marlena Jackson; Samuel Peña-Llopis; Joseph Guillory; Karen Toy; Connie Ha; Corissa J Harris; Eboni Holloman; Haley M Hill; Jeremy Stinson; Celina Sanchez Rivers; Vasantharajan Janakiraman; Weiru Wang; Lisa N Kinch; Nick V Grishin; Peter M Haverty; Bernard Chow; Julian S Gehring; Jens Reeder; Gregoire Pau; Thomas D Wu; Vitaly Margulis; Yair Lotan; Arthur Sagalowsky; Ivan Pedrosa; Frederic J de Sauvage; James Brugarolas; Somasekar Seshagiri
Journal:  Nat Genet       Date:  2014-11-17       Impact factor: 38.330

Review 3.  Purinergic signaling and energy homeostasis in psychiatric disorders.

Authors:  D Lindberg; D Shan; J Ayers-Ringler; A Oliveros; J Benitez; M Prieto; R McCullumsmith; D-S Choi
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

4.  Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK.

Authors:  Che-Chia Hsu; Xian Zhang; Guihua Wang; Weina Zhang; Zhen Cai; Bo-Syong Pan; Haiwei Gu; Chuan Xu; Guoxiang Jin; Xiangshang Xu; Rajesh Kumar Manne; Yan Jin; Wei Yan; Jingwei Shao; Tingjin Chen; Emily Lin; Amit Ketkar; Robert Eoff; Zhi-Gang Xu; Zhong-Zhu Chen; Hong-Yu Li; Hui-Kuan Lin
Journal:  Mol Cell       Date:  2021-09-16       Impact factor: 19.328

5.  Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes.

Authors:  Rafael T de Sousa; Emilio L Streck; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Andre R Brunoni; Geraldo F Busatto; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  Psychopharmacology (Berl)       Date:  2014-06-26       Impact factor: 4.530

6.  Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial.

Authors:  K L Ellis; Y Zhou; L Rodriguez-Murillo; J R Beshansky; E Ainehsazan; H P Selker; G S Huggins; L A Cupples; I Peter
Journal:  Pharmacogenomics J       Date:  2015-12-08       Impact factor: 3.550

7.  Lithium, inositol and mitochondria.

Authors:  Lilach Toker; Galila Agam
Journal:  ACS Chem Neurosci       Date:  2014-06-02       Impact factor: 4.418

Review 8.  Modeling mania in preclinical settings: A comprehensive review.

Authors:  Ajaykumar N Sharma; Gabriel R Fries; Juan F Galvez; Samira S Valvassori; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-04       Impact factor: 5.067

9.  Inositol monophosphatase 1 (IMPA1) mutation in intellectual disability patients impairs neurogenesis but not gliogenesis.

Authors:  Renata Santos; Fred H Gage; Mayana Zatz; Thalita Figueiredo; Ana P D Mendes; Danielle P Moreira; Ernesto Goulart; Danyllo Oliveira; Gerson S Kobayashi; Shani Stern; Fernando Kok; Maria C Marchetto
Journal:  Mol Psychiatry       Date:  2020-08-24       Impact factor: 15.992

Review 10.  Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects.

Authors:  Lilach Toker; Galila Agam
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.